GGrantIndex
Sort

130,381 grants matching hiv

Mechanisms Of Humoral Evasion

$1,466,332
Tongqing Zhou · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI

COLUMBIA-ADARC-CORNELL AIDS CLINICAL TRIALS UNIT

$1,466,318
Columbia University Health Sciences · U01 · FY2002 · AI

NEW JERSEY PEDIATRIC AIDS CONSORTIUM

$1,466,181
Univ Of Med/Dent Of Nj-Nj Medical School · U01 · FY2000 · AI

Mu Center for Botanical Interaction Studies

$1,465,935
Dennis B Lubahn · University Of Missouri-Columbia · P50 · FY2012 · AT

Molecular Mechanisms Of Human Immunodeficiency Virus Trans-regulatory Proteins

$1,465,849
Kuan-Teh Jeang · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI

Genetic Analysis of T-cell Differentiation

$1,465,534
Remy Bosselut · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA

JOHNS HOPKINS CENTER FOR AIDS RESEARCH

$1,465,359
Johns Hopkins University · P30 · FY2000 · AI

Dysregulation of metabolic and bioenergetic pathways by cocaine and HIV-1 in CNS

$1,465,258
Kamel Khalili · Temple Univ Of The Commonwealth · P01 · FY2016 · DA

Community-Based VCT: Thailand

$1,465,187
David D. Celentano · Johns Hopkins University · U01 · FY2009 · MH

Shotgun Sequencing of the Trichomonas Vaginalis Genome

$1,464,906
Institute For Genomic Research · U01 · FY2002 · AI

Role of HIV Envelope Proteins In Viral Replication and HIV Pathogenesis

$1,464,833
Claudia Cicala · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI

Comprehensive NeuroHIV Center

$1,464,828
Kamel Khalili · Temple Univ Of The Commonwealth · P30 · FY2025 · MH

Ancillary Studies of NAFLD and NASH in HIV infected Adults

$1,464,756
Naga P. Chalasani · Indiana University Indianapolis · R01 · FY2024 · DK

Defining Factors Controlling HIV Rebound

$1,464,427
Jerome A. Zack · University Of California Los Angeles · P01 · FY2021 · AI

Acute HIV Infection: Implications for vaccine design

$1,464,387
Marcus Altfeld · Massachusetts General Hospital · P01 · FY2010 · AI

Evaluation of doxycycline post-exposure prophylaxis to reduce sexually transmitted infections in PrEP users and HIV-infected men who have sex with men

$1,464,310
Anne Frey Luetkemeyer · University Of California, San Francisco · R01 · FY2020 · AI

Lymphocyte Dynamics

$1,463,485
William Paul · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI

Statins as Adjunctive, Host-Directed Therapy for TB

$1,463,317
Petros C Karakousis · Johns Hopkins University · UH3 · FY2019 · AI

Lactobacilli as a Delivery Vehicle for Microbicides

$1,463,248
Qiang Xu · Osel, Inc. · U19 · FY2006 · AI

Statins as Adjunctive, Host-Directed Therapy for TB

$1,463,190
Petros C Karakousis · Johns Hopkins University · UH3 · FY2018 · AI

Preclinical Evaluation of Envelope Immunogens Optimized to Elicit VRCOI-class An

$1,463,174
D. Noah Sather · Seattle Biomedical Research Institute · U19 · FY2014 · AI

ADULT AIDS CLINICAL TRIALS UNIT

$1,463,061
University Of Minnesota Twin Cities · U01 · FY2000 · AI

Technology-based Treatments for Substance Use Disorders

$1,463,035
Lisa A Marsch · Dartmouth College · P30 · FY2021 · DA

The Atlantic Coast Sexually Transmitted Infection Cooperative Research Center (AC

$1,462,783
Ann E. Jerse · Henry M. Jackson Fdn For The Adv Mil/Med · U19 · FY2017 · AI

Choosing Drug Doses for Biodefense Pathogens

$1,462,685
Ordway Research Institute, Inc. · P01 · FY2005 · AI